Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Revance Therapeutics, Inc. | rvnc1231201510kex311.htm |
| EX-21.1 - EXHIBIT 21.1 - Revance Therapeutics, Inc. | rvnc1231201510kex211.htm |
| EX-10.6 - EXHIBIT 10.6 - Revance Therapeutics, Inc. | rvnc1231201510kex106.htm |
| EX-10.34 - EXHIBIT 10.34 - Revance Therapeutics, Inc. | rvnc1231201510kex1034.htm |
| EX-10.31 - EXHIBIT 10.31 - Revance Therapeutics, Inc. | rvnc1231201510kex1031.htm |
| EX-31.2 - EXHIBIT 31.2 - Revance Therapeutics, Inc. | rvnc1231201510kex312.htm |
| EX-10.8 - EXHIBIT 10.8 - Revance Therapeutics, Inc. | rvnc1231201510kex108.htm |
| EX-32.1 - EXHIBIT 32.1 - Revance Therapeutics, Inc. | rvnc1231201510kex321.htm |
| EX-32.2 - EXHIBIT 32.2 - Revance Therapeutics, Inc. | rvnc1231201510kex322.htm |
| EX-10.27 - EXHIBIT 10.27 - Revance Therapeutics, Inc. | rvnc1231201510kex1027.htm |
| EX-10.28 - EXHIBIT 10.28 - Revance Therapeutics, Inc. | rvnc1231201510kex1028.htm |
| 10-K - 10-K - Revance Therapeutics, Inc. | rvnc1231201510k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S‑8 (Nos. 333- 193963, 333-198499, 333-203235 and 333-208543) and the Registration Statements on Form S-3 (Nos. 333-207469 and 333-202494) of Revance Therapeutics Inc. of our report dated March 4, 2016 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
San Jose, California
March 4, 2016